The enzyme-blocking drug, called a kinase inhibitor, targets a number of pathways that control the growth and death of cancer cells.It acts like several different drugs working at the same time.Scientists believe switching off cell signals at multiple points should make cancer treatment more successful and delay drug resistance.http://www.guardian.co.uk/uk/feedarticle/10330011nl
Best Of |
Favorites & Replies |
Start a New Board |
My Fool |
BATS data provided in real-time. NYSE, NASDAQ and NYSEMKT data delayed 15 minutes.
Real-Time prices provided by BATS. Market data provided by Interactive Data.
Company fundamental data provided by Morningstar. Earnings Estimates, Analyst Ra